Inside the FDA’s Quiet Move to Weaken Drug Approval Standards
Comments from the Commissioner signal that the agency is preparing to reduce clinical trial requirements. Independent experts say the change may increase the risk of ineffective or unsafe drugs reaching the market
Dec 17, 2025
